Ignacio Heras‐Murillo

1.4k total citations · 3 hit papers
7 papers, 824 citations indexed

About

Ignacio Heras‐Murillo is a scholar working on Immunology, Oncology and Physiology. According to data from OpenAlex, Ignacio Heras‐Murillo has authored 7 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 2 papers in Oncology and 2 papers in Physiology. Recurrent topics in Ignacio Heras‐Murillo's work include Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ignacio Heras‐Murillo is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Immune cells in cancer (3 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Ignacio Heras‐Murillo collaborates with scholars based in Spain, United States and United Kingdom. Ignacio Heras‐Murillo's co-authors include David Sancho, Stefanie K. Wculek, Annalaura Mastrangelo, Gillian Dunphy, Miguel Á. Galán, Sofía C. Khouili, Andrea Curtabbi, José Antonio Enrı́quez, Coral Barbas and Verónica Miguel and has published in prestigious journals such as Nature Communications, Immunity and Frontiers in Immunology.

In The Last Decade

Ignacio Heras‐Murillo

7 papers receiving 820 citations

Hit Papers

Metabolism of tissue macrophages in homeostasis and patho... 2021 2026 2022 2024 2021 2024 2023 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ignacio Heras‐Murillo Spain 6 478 284 127 91 91 7 824
Christopher M. Rice United Kingdom 5 453 0.9× 260 0.9× 101 0.8× 69 0.8× 108 1.2× 10 720
Marieli Gonzalez-Cotto United States 6 443 0.9× 258 0.9× 106 0.8× 76 0.8× 110 1.2× 10 702
Payel Roy United States 13 413 0.9× 268 0.9× 117 0.9× 101 1.1× 128 1.4× 31 816
Nicholas Jones United Kingdom 16 333 0.7× 203 0.7× 101 0.8× 149 1.6× 69 0.8× 39 830
Eslam Mohamed United States 15 699 1.5× 435 1.5× 291 2.3× 121 1.3× 88 1.0× 34 1.2k
Fabian Schorn Germany 7 358 0.7× 684 2.4× 111 0.9× 116 1.3× 114 1.3× 8 1.0k
Zhaowei Gao China 18 174 0.4× 367 1.3× 208 1.6× 79 0.9× 95 1.0× 51 864
Ruyi Xu China 9 236 0.5× 330 1.2× 88 0.7× 79 0.9× 137 1.5× 31 644

Countries citing papers authored by Ignacio Heras‐Murillo

Since Specialization
Citations

This map shows the geographic impact of Ignacio Heras‐Murillo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Heras‐Murillo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Heras‐Murillo more than expected).

Fields of papers citing papers by Ignacio Heras‐Murillo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ignacio Heras‐Murillo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Heras‐Murillo. The network helps show where Ignacio Heras‐Murillo may publish in the future.

Co-authorship network of co-authors of Ignacio Heras‐Murillo

This figure shows the co-authorship network connecting the top 25 collaborators of Ignacio Heras‐Murillo. A scholar is included among the top collaborators of Ignacio Heras‐Murillo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ignacio Heras‐Murillo. Ignacio Heras‐Murillo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Heras‐Murillo, Ignacio, Vanessa Núñez, Maite Álvarez, et al.. (2025). Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse. Nature Communications. 16(1). 3369–3369. 3 indexed citations
2.
Heras‐Murillo, Ignacio, et al.. (2024). Dendritic cells as orchestrators of anticancer immunity and immunotherapy. Nature Reviews Clinical Oncology. 21(4). 257–277. 182 indexed citations breakdown →
3.
Wculek, Stefanie K., Ignacio Heras‐Murillo, Annalaura Mastrangelo, et al.. (2023). Oxidative phosphorylation selectively orchestrates tissue macrophage homeostasis. Immunity. 56(3). 516–530.e9. 145 indexed citations breakdown →
4.
Fresno, Carlos del, Juan García‐Arriaza, Sarai Martínez-Cano, et al.. (2021). The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity. Frontiers in Immunology. 12. 748103–748103. 29 indexed citations
5.
Wculek, Stefanie K., Gillian Dunphy, Ignacio Heras‐Murillo, Annalaura Mastrangelo, & David Sancho. (2021). Metabolism of tissue macrophages in homeostasis and pathology. Cellular and Molecular Immunology. 19(3). 384–408. 255 indexed citations breakdown →
6.
Wculek, Stefanie K., et al.. (2019). Metabolic Control of Dendritic Cell Functions: Digesting Information. Frontiers in Immunology. 10. 775–775. 159 indexed citations
7.
Mira, E., Lorena Carmona‐Rodríguez, Beatriz Pérez‐Villamil, et al.. (2018). SOD3 improves the tumor response to chemotherapy by stabilizing endothelial HIF-2α. Nature Communications. 9(1). 575–575. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026